- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Nifurtoinol is an antibiotic used to treat a variety of bacterial infections. It belongs to a class of antibiotics known as nitrofurans, which are used to treat urinary tract infections, skin infections, and respiratory infections. Nifurtoinol works by inhibiting the growth of bacteria, thus preventing the spread of infection. It is available in both oral and intravenous forms.
Nifurtoinol is widely used in the medical field, as it is effective against a wide range of bacteria. It is also relatively inexpensive, making it a popular choice for treating bacterial infections. However, it is not recommended for use in pregnant women or children, as it can cause serious side effects.
The nifurtoinol market is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. These companies are constantly innovating and developing new formulations of the drug to meet the changing needs of the medical community. Show Less Read more